UPDATE: Amneal Pharmaceuticals (AMRX) Tops Q1 EPS by 2c, Revenues Miss; Offers FY21 Revenues Outlook

Go back to UPDATE: Amneal Pharmaceuticals (AMRX) Tops Q1 EPS by 2c, Revenues Miss; Offers FY21 Revenues Outlook
AmerElite Solutions, Inc. New (NASDAQ: AMRX) Delayed: 18.71 +0.43 (2.35%)
Previous Close $18.28    52 Week High $0.19 
Open $18.12    52 Week Low $0.07 
Day High $18.81    P/E N/A 
Day Low $18.06    EPS $-0.01 
Volume 6,619,073